HMA prepares to embrace EU device regulators
This article was originally published in Clinica
Executive Summary
No event has underscored more clearly the need for EU member states to co-operate more closely on how they regulate medical devices than the detection of and subsequent reaction to the discovery of allegedly fraudulent activity by the breast implant manufacturer Poly Implant Prosthèse.